LIFR also known as CD118, is a subunit of a receptor for leukemia inhibitory factor. From Wikipedia
Research identifies a new stem cell subtype and its reliance on LIFR signaling as key drivers of visceral fat gain in middle age, offering potential targets for obesity therapies.